References
- 1. Jemal A, Center MM, De Santis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarker Prev 2010; 19(8):1893-907.
- 2. NCCN Guidelines Version 1.2018. Prostate cancer. January 2018.
- 3. Brundage M, Lukka H, Crook J, et al. The use of conformal radiotherapy ant the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer- a systematic review. Radiother Oncol 2002; 64(3):12.
- 4. Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys 2009; 73(3):685-691.
- 5. Kuban DA, Tucker SL, Dong L et al. Long-term results of the MD Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008; 70:67–74.
- 6. Beckendorf V, Guerif S, Le Prise E, Cosset JM, Bougnoux A, et al. 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial. Int J Radiat Oncol Biol Phys 2011; 80: 1056–1063.
- 7. Sujenthiran A, Nossiter J, Charman SC, et al. National population-based study comparing treatment-related toxicity in men who received intensity modulated versus 3-dimensional conformal radical radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2017;99:1253-60.
- 8. Gary Luxton, Steven L. Hancock, Arthur L. Boyer. Dosimetry and radiobiological model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2004, 59 :(1): 267–284.
- 9. H.V. James, C.D. Scrase, A.J. Poynter. Practical experience with intensity-modulated radiotherapy. Br J Radiol 2004; 77: 3–14.
- 10. Edges SB, Byrd DR, Compton CC.AJCC Cancer Staging Handbook. 7th edition. New York, NY: Springer 2010.
- 11. Litzenburg D, Dawson AD, Sandler H, et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys. 2002; 52(3):699–703.
- 12. Poggi MM, Gant DA, Sewchand W, Warlick WB. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys. 2003; 56(5):1248–1251.
- 13. Drzamala RE,Mohan R, Brewster L, Chu J, Goitein M, Harms W, et al. Dose volume Histograms. Int J Radiat Oncol Biol Phys 1991; 21:71-78.
- 14. Cox JD et al.Toxicity criteria of Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31(5):1341-1346.
- 15. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam intensity-modulated radiation therapy. ICRU Report 83. Bethesda, MD: ICRU; 2010.
- 16. Feuvret L, Noel G, Mazeron JJ, Bey P. Conformity index- a review. Int J Radiat Oncol Biol Phys 2006; 64:333–42.
- 17. Yoon M, Park SY, Shin D, Lee SB, Pyo HR, Kim DY et al:A new homogeneity index based on statistical analysis of the dose-volumehistogram.J Appl Clin Med Phys 2007;8:(2):9-17.
- 18. Stangerberger A, Waldert M, Djuvan B. Prostate Cancer in elderly men. Rev Urol 2008; 10(2):111-119.
- 19. Viani GA, Stefano EJ, Alfonso SL et al. Higher than conventional radiation doses in localized prostate treatment: A meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009; 74(5):1405-18.
- 20. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D.Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53 (5):1097-1105.
- 21. Zietman AL, De Silvio MR, Slater JD et al. Comparison of conventional dose vs. high dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. JAMA 2005; 294: 1233-1239.
- 22. Vincent W.C. Wu, Dora L.W. Kwong, Jonathan S.T. Sham. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy Radiat Oncol 2004; 71: 201–206.
- 23. Gert De Meerleer, Luc Vakaet, Werner R.T. De Gersem, et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison Int J Radiat Oncol Biol Phys 2000; 47: (3) :639–648.
- 24. Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three dimensional conformal radiotherapy and intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008; 70(4): 1124-1129.